Ana‐Maria Navarrete

910 total citations
16 papers, 715 citations indexed

About

Ana‐Maria Navarrete is a scholar working on Hematology, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, Ana‐Maria Navarrete has authored 16 papers receiving a total of 715 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Hematology, 4 papers in Radiology, Nuclear Medicine and Imaging and 4 papers in Immunology. Recurrent topics in Ana‐Maria Navarrete's work include Platelet Disorders and Treatments (10 papers), Hemophilia Treatment and Research (9 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). Ana‐Maria Navarrete is often cited by papers focused on Platelet Disorders and Treatments (10 papers), Hemophilia Treatment and Research (9 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). Ana‐Maria Navarrete collaborates with scholars based in France, Belgium and Netherlands. Ana‐Maria Navarrete's co-authors include Srini V. Kaveri, Sébastien Lacroix‐Desmazes, Suryasarathi Dasgupta, Jagadeesh Bayry, Sandrine Delignat, Sébastien André, Olivier D. Christophe, Bharath Wootla, Yohann Repessé and Peter J. Lenting and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and Vaccine.

In The Last Decade

Ana‐Maria Navarrete

16 papers receiving 702 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ana‐Maria Navarrete France 13 612 141 127 124 119 16 715
Sonja van den Oudenrijn Netherlands 9 313 0.5× 30 0.2× 110 0.9× 83 0.7× 125 1.1× 10 459
M Monconduit France 9 313 0.5× 40 0.3× 231 1.8× 65 0.5× 29 0.2× 20 429
Jun Kuyama Japan 9 198 0.3× 32 0.2× 93 0.7× 40 0.3× 101 0.8× 17 327
Paul Hoecker Austria 6 259 0.4× 25 0.2× 54 0.4× 61 0.5× 152 1.3× 8 371
Τατιάνα Τζένου Greece 12 200 0.3× 45 0.3× 179 1.4× 145 1.2× 48 0.4× 26 394
Michela Rondoni Italy 13 390 0.6× 19 0.1× 123 1.0× 230 1.9× 73 0.6× 42 541
EM Mazur United States 9 366 0.6× 21 0.1× 93 0.7× 190 1.5× 58 0.5× 13 433
AM Gewirtz United States 12 383 0.6× 16 0.1× 103 0.8× 155 1.3× 93 0.8× 24 500
Femke Van Bockstaele Belgium 7 89 0.1× 50 0.4× 91 0.7× 154 1.2× 139 1.2× 9 327
OP Veiby Norway 9 381 0.6× 13 0.1× 123 1.0× 95 0.8× 225 1.9× 11 542

Countries citing papers authored by Ana‐Maria Navarrete

Since Specialization
Citations

This map shows the geographic impact of Ana‐Maria Navarrete's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ana‐Maria Navarrete with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ana‐Maria Navarrete more than expected).

Fields of papers citing papers by Ana‐Maria Navarrete

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ana‐Maria Navarrete. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ana‐Maria Navarrete. The network helps show where Ana‐Maria Navarrete may publish in the future.

Co-authorship network of co-authors of Ana‐Maria Navarrete

This figure shows the co-authorship network connecting the top 25 collaborators of Ana‐Maria Navarrete. A scholar is included among the top collaborators of Ana‐Maria Navarrete based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ana‐Maria Navarrete. Ana‐Maria Navarrete is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Legendre, Paulette, Ana‐Maria Navarrete, Julie Rayes, et al.. (2013). Mutations in the A3 domain of Von Willebrand factor inducing combined qualitative and quantitative defects in the protein. Blood. 121(11). 2135–2143. 22 indexed citations
2.
Navarrete, Ana‐Maria, Caterina Casari, Paulette Legendre, et al.. (2012). A murine model to characterize the antithrombotic effect of molecules targeting human von Willebrand factor. Blood. 120(13). 2723–2732. 16 indexed citations
3.
Pegon, Julie, Caterina Casari, Ana‐Maria Navarrete, et al.. (2012). Macrophage LRP1 contributes to the clearance of von Willebrand factor. Blood. 119(9). 2126–2134. 100 indexed citations
4.
Delignat, Sandrine, Yohann Repessé, Ana‐Maria Navarrete, et al.. (2011). Immunoprotective effect of von Willebrand factor towards therapeutic factor VIII in experimental haemophilia A. Haemophilia. 18(2). 248–254. 43 indexed citations
5.
Navarrete, Ana‐Maria, Sandrine Delignat, Jean‐Luc Teillaud, et al.. (2011). CD4+CD25+ regulatory T cell-mediated changes in the expression of endocytic receptors and endocytosis process of human dendritic cells. Vaccine. 29(15). 2649–2652. 7 indexed citations
6.
Navarrete, Ana‐Maria, Suryasarathi Dasgupta, Yohann Repessé, et al.. (2010). Endocytic receptor for pro-coagulant factor VIII: Relevance to inhibitor formation. Thrombosis and Haemostasis. 104(12). 1093–1098. 7 indexed citations
7.
Navarrete, Ana‐Maria, Suryasarathi Dasgupta, Sandrine Delignat, et al.. (2009). Splenic marginal zone antigen‐presenting cells are critical for the primary allo‐immune response to therapeutic factor VIII in hemophilia A. Journal of Thrombosis and Haemostasis. 7(11). 1816–1823. 57 indexed citations
8.
Dimitrov, Jordan D., Suryasarathi Dasgupta, Ana‐Maria Navarrete, et al.. (2009). Induction of heme oxygenase-1 in factor VIII–deficient mice reduces the immune response to therapeutic factor VIII. Blood. 115(13). 2682–2685. 22 indexed citations
9.
Lacroix‐Desmazes, Sébastien, Ana‐Maria Navarrete, Sébastien André, et al.. (2008). Dynamics of factor VIII interactions determine its immunologic fate in hemophilia A. Blood. 112(2). 240–249. 70 indexed citations
10.
Dasgupta, Suryasarathi, Ana‐Maria Navarrete, Sébastien André, et al.. (2007). Factor VIII bypasses CD91/LRP for endocytosis by dendritic cells leading to T-cell activation. Haematologica. 93(1). 83–89. 35 indexed citations
11.
Delignat, Sandrine, Suryasarathi Dasgupta, Ana‐Maria Navarrete, et al.. (2007). COMPARISON OF THE IMMUNOGENICITY OF DIFFERENT THERAPEUTIC PREPARATIONS OF HUMAN FACTOR VIII IN THE MURINE MODEL OF HEMOPHILIA A. Journal of Thrombosis and Haemostasis. 5. P–M. 2 indexed citations
12.
Delignat, Sandrine, Suryasarathi Dasgupta, Sébastien André, et al.. (2007). Comparison of the immunogenicity of different therapeutic preparations of human factor VIII in the murine model of hemophilia A. Haematologica. 92(10). 1423–1426. 36 indexed citations
13.
Dasgupta, Suryasarathi, Ana‐Maria Navarrete, Sandrine Delignat, et al.. (2007). Immune response against therapeutic factor VIII in hemophilia A patients—A survey of probable risk factors. Immunology Letters. 110(1). 23–28. 17 indexed citations
14.
Kaveri, Srini V., Suryasarathi Dasgupta, Sébastien André, et al.. (2007). Factor VIII inhibitors: role of von Willebrand factor on the uptake of factor VIII by dendritic cells. Haemophilia. 13(s5). 61–64. 26 indexed citations
15.
Dasgupta, Suryasarathi, Ana‐Maria Navarrete, Jagadeesh Bayry, et al.. (2007). A role for exposed mannosylations in presentation of human therapeutic self-proteins to CD4+ T lymphocytes. Proceedings of the National Academy of Sciences. 104(21). 8965–8970. 105 indexed citations
16.
Dasgupta, Suryasarathi, Yohann Repessé, Jagadeesh Bayry, et al.. (2006). VWF protects FVIII from endocytosis by dendritic cells and subsequent presentation to immune effectors. Blood. 109(2). 610–612. 150 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sonja van den Oudenrijn Breakdown of academic impact, for papers by M Monconduit Breakdown of academic impact, for papers by Jun Kuyama Breakdown of academic impact, for papers by Paul Hoecker Breakdown of academic impact, for papers by Τατιάνα Τζένου Breakdown of academic impact, for papers by Michela Rondoni Breakdown of academic impact, for papers by EM Mazur Breakdown of academic impact, for papers by AM Gewirtz Breakdown of academic impact, for papers by Femke Van Bockstaele Breakdown of academic impact, for papers by OP Veiby
Rankless by CCL
2026